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Pretreatment of cultured human tibroblasts with the calcium ionophore A 23 187 resulted in a decrease in 
low-density lipoprotein internalization. This effect was dose-dependent and did not occur in a medium de- 
void of calcium. About 2-fold reduction was observed with 10e5 M A 23187. In contrast, the low-density 
lipoprotein binding was only slightly affected. The incorporation of [rY]acetate and [Yloleate into all 
classes of lipids (sterol, triacylglycerols and phospholipids) was strikingly reduced by ionophore pretreat- 
ment. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The low-density lipoprotein processing by cells is 
mainly achieved by a specific receptor-mediated 
endocytosis, which results in a decrease of both 
sterol synthesis and low-density lipoprotein (LDL) 
receptor expression [l-3]. The LDL-receptor 
recycling appears to be inhibited by monovalent 
cation ionophores such as nigericin or monensin, 
which results in the disappearance of the receptors 
from the cell surface [4,5], but so far there have 
been no reports on an effect of calcium ionophores 
on LDL processing by cells. The divalent cation 
ionophore A 23187 [6] has been widely used for 
the study of calcium-dependent phenomena such 
as arachidonate release from platelets [7], human 
chorionic gonadotropin secretion by trophoblastic 
cells [8], or steroid hormone biosynthesis [9]. On 
the other hand, calcium ions are known to be in- 
volved in the control of membrane processes uch 
as capping of lectins [lo] or lateral diffusion of 
surface antigens [ 111. Hence, we investigated the 
effect of the calcium ionophore A 23187 on LDL 
and lipid metabolism in cultured human 
fibroblasts. 
2.1. Cell culture 
MRCS (human fetal lung) fibroblasts purchased 
from Biomerieux were cultivated in 30 mm Petri 
dishes containing Ham FlO medium supplemented 
with 10% foetal calf serum (Gibco), at 37”C, in a 
humidified 5% CO2 atmosphere. Experiments 
were performed on confluent cells. 
2.2. LDL preparation and labeling 
The LDL was prepared from human blood as 
described [121, and labeled according to [ 131, using 
INa (Amersham). The specific radioactivity of the 
LDL was about 250 cpm/ng. 
2.3. Effect of A 23187 on LDL binding and 
internalization 
Prior to experiments, cells were incubated for 
24 h in Ham F10 medium supplemented with 2% 
Ultroser G (Industrie Biologique Francaise), a 
serum substitute devoid of lipoproteins, for max- 
imal expression of LDL receptors, and standar- 
disation of experiments. For studies concerning the 
effect of A 23187 in relation to the drug concentra- 
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tion, cells were washed 3 times with the same 
medium, then incubated for 1 h at 37°C in Ham 
FlO medium + Ultroser (2%) + 10 mM Hepes buf- 
fer (pH 7.4), in the absence or presence of A 23187 
(Sigma) at final concentrations varying from 10m6 
to 2 x lo-’ M. The ionophore was dissolved in 
dimethyl sulfoxide (DMSO). The final concentra- 
tion of DMSO in the medium was 1 %, which does 
not impair LDL binding or internalization. Con- 
trols were performed with DMSO alone at the 
same concentrations. To study the effect of the 
drug in relation to the time of preincubation, cells 
were preincubated for 30 min-4 h with or without 
the drug (lo-’ M final concentration) in the same 
medium. For experiments designed to check the 
calcium dependence of the phenomenon, cells were 
first incubated for 30 min in Minimum Essential 
Medium (MEM) free of calcium and magnesium 
but supplemented with 1 mM EGTA, then washed 
3 times with calcium-free MEM (Gibco), and fur- 
ther incubated for 30 min in the same medium 
without EGTA, containing either DMSO alone, or 
IO-’ M A 23 187 in DMSO, in the presence or 
absence of calcium at concentrations varying from 
0.05 to 5 mM. After preincubation under specified 
conditions, the 1251-labelled LDL (5 pg/ml) was 
added, and the cells further incubated for 1 h, 
either at 4°C (binding) or 37°C (binding + inter- 
nalization). Cells were then washed 5 times with 
2 ml of an isotonic Tris-NaCl buffer (pH 7.4), 
harvested with a rubber policeman, centrifuged at 
4”C, and the radioactivity measured on the pellet 
with a Packard instrument. Protein determination 
was done on the pellet according to [14]. Results 
are expressed in percentage of controls (mean of at 
least 3 experiments). 
2.4. Effect of A 23187 on lipid synthesis 
Experiments were performed with sodium 
[I-‘4C]acetate (48 mCi/mmol, Amersham), or 
[l-‘4C]oleic acid (52 mCi/mmol, Amersham). 
Prior to experiments, cells were cultured for 24 h 
either in Ham FlO medium + 2% Ultroser (for 
acetate incorporation), or in Ham FlO medium + 
10% foetal calf serum (for oleate incorporation). 
Cells were then preincubated for 1 h with either 
A 23187 (final concentration 10m5 M) dissolved in 
DMSO (1% final concentration), or DMSO alone 
(controls). The precursor ([14C]acetate, lO/rCi/ml 
or [‘4C]oleate, 0.5 &i/ml) was then added and a 
further 4-h incubation performed. Cells were then 
extensively washed, and lipid analysis performed 
by thin-layer chromatography according to [ 151. 
Results are expressed in pmol precursor incor- 
porated/mg cellular proteins (mean of 3 ex- 
perimental values f SD). 
3. RESULTS AND DISCUSSION 
Fig.1 displays the effect of A 23187 in relation 
to the drug concentration (1 h preincubation of 
cells with the drug, then 1 h incubation with 1251- 
labelled LDL at either 4 or 37°C). LDL inter- 
nalization was decreased in a dose-dependent man- 
ner, whereas LDL binding was only slightly af- 
fected. The maximal effect on LDL internalization 
was obtained at 10m5 M (about 2-fold decrease 
compared to controls), and plateaued at higher 
concentrations. 
Fig.2 displays the effects of the drug (10e5 M) in 
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Fig. 1. Effects of the ionophore A 23 187 on LDL binding 
and internalization by cultured human fibroblasts, in 
relation to the drug concentration. For experimental 
conditions, see section 2. Results are expressed in % of 
control values (DMSO alone). Each point is the mean of 
at least 3 experimental values. (0) Binding (100% = 
82.5 f 12.6 ng 1251-LDL/mg cell protein); (v) 
internalization (100% = 532 +- 46 ng 12?-LDL/mg cell 
protein). 
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Fig.2. Effects of the ionophore A 23 187 on LDL binding 
and internalization, in relation to the preincubation time 
of cells with the drug. For experimental conditions, see 
section 2. Results are expressed in % of control values 
(DMSO alone). Each point is the mean of 3 experimental 
values. (0) Binding (100% = 89.7 k 11.5 ng lz51- 
LDL/mg cell protein); (v) internalization (100% = 
546 f 29 ng “‘I-LDL/mg of cell protein). 
the maximal decrease in LDL internalization was 
obtained within 30 min of preincubation. In con- 
trast, the LDL binding was only slightly affected 
up to 4 h preincubation. 
Fig.3 displays the influence of the calcium con- 
centration in the incubation medium on the effect 
of A 23187 on LDL internalization. Note that 
ionophore A 23187 had no effect on LDL inter- 
nalization in a medium completely devoid of 
calcium. The maximal effect was obtained with 
0.5 mM calcium. This clearly demonstrates that 
the decrease in LDL internalization induced by 
A 23 187 was related to the calcium influx into cells 
and not to a possible effect of the drug itself. This 
last hypothesis had especially to be ruled out, as 
A 23187 is a hydrophobic compound, which could 
interfere with membranes and thus could alter the 
LDL receptor-mediated endocytosis, as has been 
previously found for other hydrophobic drugs 
[16,17]. 
It can be seen in table 1 that a 2-h preincubation 
of the cells with 10e5 M A 23187 induced a 
dramatic decrease in [14C]acetate incorporation in- 
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Fig.3. Influence of the calcium concentration of the 
medium on the effect of A 23187 on LDL 
internalization. For experimental conditions, see section 
2. Results are expressed in % of control values. Each 
point is the mean of 3 experimental values. 100% = 
562 + 37 ng “‘1-LDL/mg cell protein. 
to all classes of lipids studied (sterols, 
triacylglycerols and phospholipids). This effect is 
more marked for sterols and phospholipids, which 
have a faster turnover than triacylglycerols. 
Moreover, table 1 shows that the pretreatment of 
the cells with A 23187 also resulted in a marked 
decrease of [‘4C]oleic acid incorporation into 
cholesteryl esters and triacylglycerols. It must be 
noted that in all experiments, cell viability was not 
significantly affected, and that if in some cases 
A 23187 induced a significant detachment of the 
cells from the support, only attached cells were 
analyzed for precursor incorporation into lipids or 
for LDL binding and internalization. 
The effects of the calcium ionophore A 23187 
on LDL and lipid metabolism in cultured 
fibroblasts have not previously been reported. The 
only ionophores which have been studied at the 
present time for their interaction with LDL pro- 
cessing by cells are monensin and nigericin [4,5]. 
These drugs are monovalent cationic ionophores, 
and abolish the Na+/K+ gradient. They have been 
demonstrated to decrease rapidly the number of 
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Table 1 
Effect of ionophore A 23187 on the incorporation of [‘4C]acetate and [‘4Cloleate into lipids 
Lipid Drug [ 1 -‘4C]Acetate [ 1-14C]01eate 
incorporation incorporation 
(pmol/mg protein) (pmol/mg protein) 
Sterols Control 870 f 140 (100%) 0 
A 23187 131 s 16 ( 15%) 0 
Cholesterylesters Control n.d. 1364 f 190 (100%) 
A 23187 n.d. 380 + 68 ( 28%) 
Triacylglycerols Control 1245 + 206 (100%) 8355 f 916 (100%) 
A 23187 450 f 74 ( 36%) 1921 + 290 ( 22%) 
Total phospholipids Control 25460 + 4580 (100%) 17352 k 2260 (100%) 
A 23187 3055 + 575 ( 12%) 5550 f 870 ( 32%) 
Prior to experiments, cells were cultured 24 h either in Ham FlO + 2% Ultroser (for further study 
of acetate incorporation), or Ham FlO + 10% fetal calf serum (for study of oleate incorporation). 
Ionophore (10m5 M final concentration), dissolved in DMSO (1% final concentration), or DMSO 
alone (controls) were then added for 1 h. After preincubation, the precursor was added 
([14C]acetate, 10 &i/ml; [‘4C]oleate, 0.5 &i/ml), and further incubation performed during 4 h. 
Lipid analysis was performed by thin-layer chromatography. Results are expressed in pmol 
precursor incorporated/mg cellular protein k SD (mean of 3 experimental values) 
LDL receptors at the cell surface by interrupting 
receptor recycling [4]. From our results, the 
calcium ionophore A 23187 had a clearly different 
effect: there was no significant decrease in the 
number of LDL receptors at the cell surface, and 
only a slight increase for long incubation times 
(24 h). In contrast, LDL internalization was 
markedly inhibited. Note that cells treated with 
A 23 187 exhibited, only in the presence of calcium, 
a rounded shape, which suggests alterations in the 
cytoskeleton. The effect of increasing intracellular 
calcium concentration on cell shape is well 
documented for the red cell [ 18-201. Authors in 
[20] reported that in the presence of calcium + 
A 23 187, the human erythrocyte morphology turns 
from discocyte to a rounded echinocyte mor- 
phology. This phenomenon was associated with a 
decrease in the intracellular ATP content [20]. The 
increase in the intracellular calcium concentration 
in red cells has also been found to increase the 
membrane rigidity [21] and to induce cross-linking 
of contractile proteins [22]. Such phenomena 
could be involved in the decrease of LDL en- 
docytosis described here. Note that the mor- 
phological changes which we observed in cells 
treated with A 23187 were parallel with the effect 
of the ionophore on LDL endocytosis: neither a 
significant decrease in LDL internalization nor 
morphological alteration of cells were found for 
calcium concentrations lower than 0.2 mM. In 
some experiments in which the ionophore and the 
LDL were simultaneously introduced and the LDL 
internalization studied at 10, 20, and 30 min, we 
also observed a decrease in LDL internalization, 
but less marked than in experiments performed 
with preincubation (about 2%30% reduction, 
compared to a 2-fold decrease in cells preincubated 
30 min with the ionophore, not shown). This could 
be due to the rapid internalization of the LDL in 
the first minutes, as the cells turned to a rounded 
shape only after lo-15 min of incubation with the 
ionophore. 
The strong decrease in acetate and oleic acid in- 
corporation into lipids induced by cell pretreat- 
ment with A 23187 remains difficult to explain. 
Authors in [9] reported a suppressive effect of 
A 23187 on the stimulatory action of luteinizing 
hormone on progesterone synthesis by ovarian 
cells in vitro. These authors also found an inhibi- 
tion of protein synthesis by A 23187 in the 
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presence of calcium [9]. It can be supposed that in 
our experimental system, the inhibition of lipid 
synthesis by A 23 187 could be related to the 
decrease in the intracellular ATP content [18], 
or/and to an effect of the ionophore on calcium- 
dependent processes involved in the regulation of 
lipid metabolism. Another hypothesis is that cross- 
linking of membrane proteins resulted in arresting 
cells and thus led to a decrease in all metabolism. 
In any case, this effect appears to be non-specific, 
as the synthesis of all the lipids studied was af- 
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